Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nikkiso’s medical division manufactures and markets commercialized hemodialysis machines and disposables globally. The company pioneered Japan’s first dialysis machine in the late '60s and remains one of the world’s largest suppliers of blood purification devices. Its DBB series hemodialysis systems are widely used in clinical practice worldwide. The company also offers leukocyte apheresis systems since their EU launch in the early 2010s. No clinical trial results are reported as they provide regulated medical devices rather than drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nikkiso.